<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8111117</journal-id>
<journal-id journal-id-type="pubmed-jr-id">20584</journal-id>
<journal-id journal-id-type="nlm-ta">Clin Psychol Rev</journal-id>
<journal-id journal-id-type="iso-abbrev">Clin Psychol Rev</journal-id>
<journal-title-group>
<journal-title>Clinical psychology review</journal-title>
</journal-title-group>
<issn pub-type="ppub">0272-7358</issn>
<issn pub-type="epub">1873-7811</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27876165</article-id>
<article-id pub-id-type="pmc">5423866</article-id>
<article-id pub-id-type="doi">10.1016/j.cpr.2016.11.003</article-id>
<article-id pub-id-type="manuscript">NIHMS831539</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Application of Research Domain Criteria to childhood and adolescent impulsive and addictive disorders: Implications for treatment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yip</surname>
<given-names>Sarah W.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Potenza</surname>
<given-names>Marc N.</given-names>
</name>
<xref ref-type="corresp" rid="CR1">*</xref>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut</aff>
<aff id="A2"><label>2</label>CASAColumbia, Yale University School of Medicine, New Haven, Connecticut</aff>
<aff id="A3"><label>3</label>Child Study Center, Yale University School of Medicine, New Haven, Connecticut</aff>
<aff id="A4"><label>4</label>Department of Neurobiology, Yale University School of Medicine, New Haven, Connecticut</aff>
<author-notes>
<corresp id="CR1"><label>*</label> Author for correspondence: Connecticut Mental Health Center, Room S-104 34 Park St. New Haven, CT 06519; Tel: 203-974-7356; Fax: 203-974-7366; <email>marc.potenza@yale.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>2</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>09</day>
<month>11</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>8</month>
<year>2019</year>
</pub-date>
<volume>64</volume>
<fpage>41</fpage>
<lpage>56</lpage>
<!--elocation-id from pubmed: 10.1016/j.cpr.2016.11.003-->
<abstract>
<p id="P1">The Research Domain Criteria (RDoC) initiative provides a large-scale, dimensional framework for the integration of research findings across traditional diagnoses, with the long-term aim of improving existing psychiatric treatments. A neurodevelopmental perspective is essential to this endeavor. However, few papers synthesizing research findings across childhood and adolescent disorders exist. Here, we discuss how the RDoC framework may be applied to the study of childhood and adolescent impulsive and addictive disorders in order to improve neurodevelopmental understanding and to enhance treatment development. Given the large scope of RDoC, we focus on a single construct highly relevant to addictive and impulsive disorders â€“ initial responsiveness to reward attainment. Findings from genetic, molecular, neuroimaging and other translational research methodologies are highlighted.</p>
</abstract>
<kwd-group>
<kwd>dopamine</kwd>
<kwd>development</kwd>
<kwd>substance use</kwd>
<kwd>impulsivity</kwd>
<kwd>fMRI</kwd>
<kwd>reward sensitivity</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>